These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38861356)

  • 1. Mitoxantrone ameliorates ineffective erythropoiesis in a β-thalassemia intermedia mouse model.
    Zhang H; Liu R; Fang Z; Nie L; Ma Y; Sun F; Mei J; Song Z; Ginzburg YZ; Liu J; Chen H
    Blood Adv; 2024 Aug; 8(15):4017-4024. PubMed ID: 38861356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia.
    Manolova V; Nyffenegger N; Flace A; Altermatt P; Varol A; Doucerain C; Sundstrom H; Dürrenberger F
    J Clin Invest; 2019 Dec; 130(1):491-506. PubMed ID: 31638596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of β-thalassemia with blood transfusions.
    Kalleda N; Flace A; Altermatt P; Ingoglia G; Doucerain C; Nyffenegger N; Dürrenberger F; Manolova V
    Haematologica; 2023 Oct; 108(10):2703-2714. PubMed ID: 37165842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Roles of Mitophagy and Autophagy in Ineffective Erythropoiesis in β-Thalassemia.
    Chaichompoo P; Svasti S; Smith DR
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of heme oxygenase ameliorates anemia and reduces iron overload in a β-thalassemia mouse model.
    Garcia-Santos D; Hamdi A; Saxova Z; Fillebeen C; Pantopoulos K; Horvathova M; Ponka P
    Blood; 2018 Jan; 131(2):236-246. PubMed ID: 29180398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis.
    Liang R; Lin M; Menon V; Qiu J; Menon A; Breda L; Arif T; Rivella S; Ghaffari S
    Blood Adv; 2023 Nov; 7(22):6873-6885. PubMed ID: 37672319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia.
    Suragani RN; Cawley SM; Li R; Wallner S; Alexander MJ; Mulivor AW; Gardenghi S; Rivella S; Grinberg AV; Pearsall RS; Kumar R
    Blood; 2014 Jun; 123(25):3864-72. PubMed ID: 24795345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous iron increases hemoglobin in beta-thalassemic mice.
    Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
    Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model.
    Matte A; Federti E; Kung C; Kosinski PA; Narayanaswamy R; Russo R; Federico G; Carlomagno F; Desbats MA; Salviati L; Leboeuf C; Valenti MT; Turrini F; Janin A; Yu S; Beneduce E; Ronseaux S; Iatcenko I; Dang L; Ganz T; Jung CL; Iolascon A; Brugnara C; De Franceschi L
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33822774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. betaMinor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in beta thalassemic mice after erythropoietin complementary DNA electrotransfer in muscles.
    Samakoglu S; Fattori E; Lamartina S; Toniatti C; Stockholm D; Heard JM; Bohl D
    Blood; 2001 Apr; 97(8):2213-20. PubMed ID: 11290581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.
    Dussiot M; Maciel TT; Fricot A; Chartier C; Negre O; Veiga J; Grapton D; Paubelle E; Payen E; Beuzard Y; Leboulch P; Ribeil JA; Arlet JB; Coté F; Courtois G; Ginzburg YZ; Daniel TO; Chopra R; Sung V; Hermine O; Moura IC
    Nat Med; 2014 Apr; 20(4):398-407. PubMed ID: 24658077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia.
    Matte A; Federti E; Winter M; Koerner A; Harmeier A; Mazer N; Tomka T; Di Paolo ML; De Falco L; Andolfo I; Beneduce E; Iolascon A; Macias-Garcia A; Chen JJ; Janin A; Lebouef C; Turrini F; Brugnara C; De Franceschi L
    JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31593554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AZD8055 Is More Effective Than Rapamycin in Inhibiting Proliferation and Promoting Mitochondrial Clearance in Erythroid Differentiation.
    Liu Q; Hao T; Lin Z; Fang Y; Li L; Huang D; Wu J; Zhao Y; Zhang X
    Anal Cell Pathol (Amst); 2024; 2024():2639464. PubMed ID: 39411209
    [No Abstract]   [Full Text] [Related]  

  • 14. Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle.
    Bohl D; Bosch A; Cardona A; Salvetti A; Heard JM
    Blood; 2000 May; 95(9):2793-8. PubMed ID: 10779423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.
    Rivella S; May C; Chadburn A; Rivière I; Sadelain M
    Blood; 2003 Apr; 101(8):2932-9. PubMed ID: 12480689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus.
    Zurlo M; Zuccato C; Cosenza LC; Gasparello J; Gamberini MR; Stievano A; Fortini M; Prosdocimi M; Finotti A; Gambari R
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective erythropoiesis and HbF reactivation induced by kit ligand in beta-thalassemia.
    Gabbianelli M; Morsilli O; Massa A; Pasquini L; Cianciulli P; Testa U; Peschle C
    Blood; 2008 Jan; 111(1):421-9. PubMed ID: 17951528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell profiling of ineffective erythropoiesis in a mouse model of β-thalassaemia intermedia.
    Peng Y; Liang L; Zhang H; Liu H; Zhang G; Sun S; Guo X; Wang Y; Hu B; Liu R; Li Y; Nie L; Zhang J; Ye M; Ginzburg YZ; Lin Z; Yin B; Chen H; Liu J
    Br J Haematol; 2023 Jun; 201(5):982-994. PubMed ID: 36872867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of β-Thalassemia.
    Nyffenegger N; Flace A; Doucerain C; Dürrenberger F; Manolova V
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulatory and compensatory responses in hematopoiesis/erythropoiesis in alpha- and beta-globin hemizygous mice.
    Beauchemin H; Blouin MJ; Trudel M
    J Biol Chem; 2004 May; 279(19):19471-80. PubMed ID: 15004025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.